Benzinga | Mar 22, 2021 08:22AM EDT

Decibel Therapeutics Added To Russell 2000 Index

Decibel Therapeutics (NASDAQ:DBTX) ("Decibel"), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that it has been added to the Russell 2000(r) Index, as part of the index's quarterly initial public offering ("IPO") additions.

Russell's U.S. indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $9 trillion in assets are benchmarked against Russell's U.S. indexes. Russell Indexes are part of FTSE Russell, a leading global index provider.

For more information about the Russell U.S. Indexes and the Russell Indexes reconstitution, visit the FTSE Russell website.